Does LAROTRECTINIB Cause Myalgia? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Myalgia have been filed in association with LAROTRECTINIB (VITRAKVI). This represents 2.9% of all adverse event reports for LAROTRECTINIB.
23
Reports of Myalgia with LAROTRECTINIB
2.9%
of all LAROTRECTINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Myalgia From LAROTRECTINIB?
Of the 23 reports, 1 (4.3%) required hospitalization.
Is Myalgia Listed in the Official Label?
Yes, Myalgia is listed as a known adverse reaction in the official FDA drug label for LAROTRECTINIB.
What Other Side Effects Does LAROTRECTINIB Cause?
Fatigue (56)
Drug ineffective (52)
Dizziness (50)
Death (48)
Pain (42)
Neuropathy peripheral (39)
Nausea (32)
Off label use (31)
Disease progression (27)
Malignant neoplasm progression (23)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which LAROTRECTINIB Alternatives Have Lower Myalgia Risk?
LAROTRECTINIB vs LASILIX
LAROTRECTINIB vs LASIX
LAROTRECTINIB vs LASMIDITAN
LAROTRECTINIB vs LATANOPROST
LAROTRECTINIB vs LATANOPROSTENE BUNOD